Bicocca Open Archive

Logo unimib boa
ALIBERTI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.109
EU - Europa 3.971
AS - Asia 1.930
SA - Sud America 121
AF - Africa 26
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 3
Totale 15.173
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.929
CN - Cina 721
RU - Federazione Russa 709
DE - Germania 701
SG - Singapore 610
SE - Svezia 582
UA - Ucraina 524
IE - Irlanda 469
HK - Hong Kong 390
IT - Italia 377
CA - Canada 174
GB - Regno Unito 167
FI - Finlandia 125
AT - Austria 109
BR - Brasile 109
FR - Francia 90
VN - Vietnam 70
IN - India 45
NL - Olanda 32
CZ - Repubblica Ceca 25
ID - Indonesia 24
TR - Turchia 18
DK - Danimarca 17
BE - Belgio 13
ZA - Sudafrica 13
JP - Giappone 10
NZ - Nuova Zelanda 7
PL - Polonia 7
AU - Australia 6
IQ - Iraq 6
BG - Bulgaria 5
ES - Italia 5
IR - Iran 5
EG - Egitto 4
LB - Libano 4
TH - Thailandia 4
BD - Bangladesh 3
CH - Svizzera 3
CO - Colombia 3
MX - Messico 3
PA - Panama 3
PE - Perù 3
PT - Portogallo 3
VE - Venezuela 3
AR - Argentina 2
AZ - Azerbaigian 2
EU - Europa 2
GR - Grecia 2
KR - Corea 2
MD - Moldavia 2
SA - Arabia Saudita 2
SC - Seychelles 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
CM - Camerun 1
DZ - Algeria 1
EC - Ecuador 1
GE - Georgia 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
PK - Pakistan 1
RO - Romania 1
TJ - Tagikistan 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 15.173
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.381
Woodbridge 1.161
Fairfield 865
Houston 766
Jacksonville 565
Dublin 458
Chandler 456
Ashburn 433
Singapore 404
Hong Kong 387
Wilmington 363
Seattle 351
Dearborn 346
Cambridge 302
Frankfurt am Main 250
Princeton 225
New York 193
Nanjing 119
Altamura 108
Hangzhou 107
Milan 104
Santa Clara 104
Beijing 101
Lachine 97
Lawrence 95
Vienna 95
Shanghai 90
Moscow 80
Nanchang 46
San Diego 39
Shenyang 32
Ottawa 31
Dong Ket 30
Hebei 29
Jiaxing 26
Toronto 24
Brno 23
Andover 22
Norwalk 22
Council Bluffs 21
Tianjin 21
Falls Church 20
Helsinki 20
Jakarta 20
Guangzhou 19
Jinan 19
Munich 18
Ningbo 17
Mountain View 16
London 15
Changsha 14
Fremont 14
Huizen 14
Boardman 13
Chicago 12
Hefei 12
Brussels 11
Kunming 10
Los Angeles 9
Zhengzhou 9
Beauharnois 8
Lissone 8
The Dalles 8
Düsseldorf 7
Kilburn 7
Nuremberg 7
San Francisco 7
Rome 6
San Mateo 6
São Paulo 6
Edmonton 5
Lappeenranta 5
Montréal 5
Naples 5
Newark 5
Phoenix 5
Redmond 5
Sacramento 5
Taizhou 5
Turin 5
Auckland 4
Bangkok 4
Lauterbourg 4
Nürnberg 4
Sofia 4
University Park 4
Ankara 3
Auburn Hills 3
Bari 3
Basra 3
Bexley 3
Brasília 3
Brooklyn 3
Campodarsego 3
Cincinnati 3
Congonhas 3
Dallas 3
Groningen 3
Hanoi 3
Jaipur 3
Totale 10.840
Salva come PNG Salva come JPEG
Nome #
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 313
Impact of age and comorbidity on cause and outcome in community-acquired pneumonia 249
Dyspnea in crackling lungs 231
Delirium symptoms during hospitalization predict long-term mortality in patients with severe pneumonia 224
Impact of traffic-related air pollution on pulmonary oxidative stress 220
Cardiovascular autonomic alterations in hospitalized patients with community-acquired pneumonia 206
Influenza A/H1N1 severe pneumonia: Novel morphocytological findings in bronchoalveolar lavage 205
Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases 203
Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: Do we need a personalized approach? 203
Clinical phenotypes in adult patients with bronchiectasis 199
Diaphragm ultrasonography in the management of patients with amyotrophic lateral sclerosis 196
Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics 190
Multidimensional severity assessment in bronchiectasis: An analysis of seven European cohorts 188
A 61-year-old female with chronic cough and purulent sputum 186
A 13-year-old female with shortness of breath and pleuritic chest pain 185
Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity 182
Mixed community-acquired lower respiratory tract infections 181
Prulifloxacin: A brief review of its potential in the treatment of acute exacerbation of chronic bronchitis 173
Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: A multinational point prevalence study of hospitalised patients 172
Hospital admission decision for patients with community-acquired pneumonia 171
Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia 166
Mortality in acute cardiogenic pulmonary edema treated with continuous positive airway pressure 164
Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study 163
The management of community-acquired pneumonia in the elderly 162
The role of lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia 161
Chlamydia pneumoniae and acute aortic syndrome: A call for a multi-institutional study 159
Helmet CPAP vs. oxygen therapy in severe hypoxemic respiratory failure due to pneumonia 159
Early administration of the first antimicrobials should be considered a marker of optimal care of patients with community-acquired pneumonia rather than a predictor of outcomes 158
Phenotyping in Bronchiectasis: Are we moving towards a personalized medicine? 158
Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study 157
Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study 155
Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis 154
Microbiological Diagnosis and Antibiotic Therapy in Patients with Community-Acquired Pneumonia and Acute COPD Exacerbation in Daily Clinical Practice: Comparison to Current Guidelines 152
Geriatric multidimensional assessment for elderly patients with acute respiratory diseases 151
Contrasting Inflammatory Responses in Severe and Non-severe Community-acquired Pneumonia 150
Strategic targets of essential host-pathogen interactions 149
Non-invasive continuous positive airway pressure in monolateral lung transplant patient with pneumonia and IPF 149
Serum and exhaled breath condensate inflammatory cytokines in community-acquired pneumonia: a prospective cohort study 149
Pneumonia: how important are local epidemiology and smoking habits? 148
Criteria for clinical stability in hospitalised patients with community-acquired pneumonia 147
100 years of respiratory medicine: pneumonia 145
Compliance with anti-H1N1 vaccine among healthcare workers and general population 144
COPD and bronchiectasis: Phenotype, endotype or co-morbidity? 143
The Clinical and Economic Impact of Exacerbations of Chronic Obstructive Pulmonary Disease: A Cohort of Hospitalized Patients 142
Should health care systems and health care providers implement a new pathway for hospitalized patients with community-acquired pneumonia? 140
The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study 140
Impact of exacerbations in the natural course of COPD 139
The bronchiectasis severity index. An international derivation and validation study 138
Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis 138
Predicting Mycobacterium tuberculosis in patients with community-acquired pneumonia 136
Validation of the 3CPO-score in a prospective cohort of Acute Cardiogenic Pulmonary Edema (ACPE) patients 136
Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection 135
Usefulness of simplified acute physiology score II in predicting mortality in patients admitted to an emergency medicine ward 135
Individualizing duration of antibiotic therapy in community-acquired pneumonia 135
International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia 135
Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia 134
Are multi-drug resistant (MDR) pathogens related to higher mortality in pneumonia? 134
Noninvasive ventilation or continuous positive airway pressure in pulmonary edema patients with respiratory acidosis? Look at the bicarbonates 133
Acute myocardial infarction versus other cardiovascular events in communityacquired pneumonia 133
The role of biomarkers in low respiratory tract infections 133
Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy 132
Stratifying Risk Factors for Multidrug-Resistant Pathogens in Hospitalized Patients Coming From the Community With Pneumonia 132
Do prognostic factors help physicians in predicting legionellosis' respiratory complications? 132
Nosocomial transmission of carbapenem-resistant Klebsiella pneumoniae in an Italian university hospital: a molecular epidemiological study 132
Azithromycin and lower respiratory tract infections 131
Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia 129
Acidemia does not affect outcomes of patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure 128
Antibiotics as immunomodulant agents in COPD 128
Early application of non-invasive continuous positive airway pressure in acute respiratory distress syndrome due to a drug overdose: a case report 127
Clinical and economical impact of exacerbations of chronic obstructive pulmonary disease (COPD): a two year study 127
Pneumococcal Vaccine and Patients with Pulmonary Diseases 125
Chlamydophila pneumoniae 124
Pneumonia in the community caused by multidrug-resistant organisms: keep working on probabilistic scores 123
Low CURB-65 is of limited value in deciding discharge of patients with community-acquired pneumonia 122
Acute exacerbation of COPD: application of evidence-based guidelines 122
Management of nontuberculous mycobacterial infection in the elderly 121
Where are the acutely ill best cared for and who should look after them? 120
The management of patients with community-acquired pneumonia beyond antibiotic therapy 120
Cardiac diseases complicating community-acquired pneumonia 117
Is it time for a "pneumo-geriatrician" for frail old patients with respiratory diseases? 116
Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia 115
Clinical Stability versus Clinical Failure in Patients with Community-Acquired Pneumonia 115
Telithromycin in lower respiratory tract infections 114
Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia 114
Clinical applications of azithromycin microspheres in respiratory tract infections 111
Acute myocardial infarction in hospitalized patients with community-acquired pneumonia 111
Non-invasive-ventilation in H1N1 acute respiratory failure in emergency department: A case series 111
Chlamydia pneumoniae and Mycoplasma pneumoniae 110
The pneumonia severity index and the CRB-65 in cancer patients with community-acquired pneumonia 109
Highlights on the appropriate use of fluoroquinolones in respiratory tract infections 107
The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia 106
Healthcare-associated pneumonia: where do we go next? 103
Association between time to clinical stability and outcomes after discharge in hospitalized patients with community-acquired pneumonia 103
“Normotension” on admission to the emergency department affects outcome of patients with acute cardiogenic pulmonary edema (ACPE) 101
Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective 100
Acute effects of positive end-expiratory pressure on left ventricle diastolic function in healthy subjects 99
Chlamydophila pneumoniae induces a sustained airway hyperresponsiveness and inflammation in mice 98
Helmet continuous positive airway pressure vs oxygen therapy to improve oxygenation in community-acquired pneumonia: a randomized, controlled trial 96
Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia 96
Clinical failure in hospitalized patients with community acquired pneumonia (CAP): Preliminary results from the FAILCAP study 95
Totale 14.558
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.202
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.202
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020243 0 0 0 0 0 0 0 0 0 0 175 68
2020/20211.586 134 84 165 168 108 82 145 139 146 219 69 127
2021/20221.059 51 102 104 90 52 103 55 61 64 86 93 198
2022/20231.833 250 532 224 133 92 315 9 90 133 4 25 26
2023/20241.249 35 32 47 31 172 335 254 57 153 15 10 108
2024/20252.378 205 348 76 141 275 60 82 79 313 474 325 0
Totale 15.400